As described above, Chang et al. demonstrated that plasma miR-141 is a novel biomarker that complements carcinoembryonic antigen (CEA) in the detection of colon cancer with distant metastasis, and that high expression levels of miR-141 in plasma were associated with a poor prognosis [38]. Here, CEACAM5 is linked to colonic neoplasm.